Strength
500 ug/1
Manufacturer
Solco Healthcare US LLCNDC
43547000503
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208299On Market Since
5/10/2022
Pharmacological Classes
Phosphodiesterase 4 Inhibitor
Phosphodiesterase 4 Inhibitors
Related Drugs
Same classification
ROFLUMILAST 500 MCG TABLET
Generic
00904739946•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904739989•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904748303•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
00904748389•Major Pharmaceuticals
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
31722062330•Camber Pharmaceuticals Inc.
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
31722062390•Camber Pharmaceuticals Inc.
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
42571025930•Micro Labs Limited
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
59651027530•Aurobindo Pharma Limited
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
59651027590•Aurobindo Pharma Limited
$0.3187
per EA
ROFLUMILAST 500 MCG TABLET
Generic
60687078621•American Health Packaging
$0.3187
per EA